The Role of Tranexamic Acid in Managing Traumatic Hemorrhage: A Review of Current Evidence
DOI:
https://doi.org/10.12775/QS.2026.54.70843Keywords
Tranexamic acid, Traumatic hemorrhage, Antifibrinolytic therapy, Trauma, Timing of administration, Route of administrationAbstract
Introduction. Traumatic hemorrhage is one of the leading causes of death among patients with severe injuries. Tranexamic acid (TXA), a synthetic antifibrinolytic agent, has shown potential to reduce massive blood loss and decrease mortality.
Aim. The aim of this study was to analyze current evidence regarding the efficacy and safety of tranexamic acid in the treatment of traumatic hemorrhage and to assess the factors influencing its therapeutic effect.
Methods. A literature review was conducted covering publications (2010-2026), including clinical studies, randomized controlled trials, systematic reviews, and meta-analyses concerning the use of TXA in trauma patients. Data on the timing and route of administration, dosing, efficacy, and safety of therapy were analyzed.
Results. TXA reduces blood loss and may lower mortality, especially when administered early after injury. Intravenous use is standard, while intraosseous or intramuscular routes may be used prehospital. TXA is generally safe, but monitoring for thromboembolic events and dose-related adverse effects is recommended in patients with multiple injuries.
Conclusions. TXA is an effective and safe option in traumatic hemorrhage management. Its efficacy depends on timing, dosing, and patient factors. Early use improves outcomes, but further research is needed to optimize treatment and assess alternative administration routes.
References
1. Halvachizadeh S, Mariani D, Pfeifer R. Impact of trauma on society. Eur J Trauma Emerg Surg. 2025 Mar 26;51(1):155. doi: 10.1007/s00068-025-02824-8. PMID: 40140090; PMCID: PMC11946998.
2. Brohi K, Gruen RL, Holcomb JB. Why are bleeding trauma patients still dying? Intensive Care Med. 2019 May;45(5):709-711. doi: 10.1007/s00134-019-05560-x. Epub 2019 Feb 11. PMID: 30741331.
3. Rossaint R, Afshari A, Bouillon B, Cerny V, Cimpoesu D, Curry N, Duranteau J, Filipescu D, Grottke O, Grønlykke L, Harrois A, Hunt BJ, Kaserer A, Komadina R, Madsen MH, Maegele M, Mora L, Riddez L, Romero CS, Samama CM, Vincent JL, Wiberg S, Spahn DR. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care. 2023 Mar 1;27(1):80. doi: 10.1186/s13054-023-04327-7. PMID: 36859355; PMCID: PMC9977110.
4. Moore EE, Moore HB, Kornblith LZ, Neal MD, Hoffman M, Mutch NJ, Schöchl H, Hunt BJ, Sauaia A. Trauma-induced coagulopathy. Nat Rev Dis Primers. 2021 Apr 29;7(1):30. doi: 10.1038/s41572-021-00264-3. Erratum in: Nat Rev Dis Primers. 2022 Apr 22;8(1):25. doi: 10.1038/s41572-022-00360-y. PMID: 33927200; PMCID: PMC9107773.
5. Franchini M, Mannucci PM. The never ending success story of tranexamic acid in acquired bleeding. Haematologica. 2020 May;105(5):1201-1205. doi: 10.3324/haematol.2020.250720. Epub 2020 Mar 26. PMID: 32336684; PMCID: PMC7193503.
6. CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14. PMID: 20554319.
7. CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019 Nov 9;394(10210):1713-1723. doi: 10.1016/S0140-6736(19)32233-0. Epub 2019 Oct 14. Erratum in: Lancet. 2019 Nov 9;394(10210):1712. doi: 10.1016/S0140-6736(19)32641-8. PMID: 31623894; PMCID: PMC6853170.
8. Prutsky G, Domecq JP, Salazar CA, Accinelli R. Antifibrinolytic therapy to reduce haemoptysis from any cause. Cochrane Database Syst Rev. 2016 Nov 2;11(11):CD008711. doi: 10.1002/14651858.CD008711.pub3. PMID: 27806184; PMCID: PMC6464927.
9. Prudovsky I, Carter D, Kacer D, Palmeri M, Soul T, Kumpel C, Pyburn K, Barrett K, DeMambro V, Alexandrov I, Brandina I, Kramer R, Rappold J. Tranexamic acid suppresses the release of mitochondrial DNA, protects the endothelial monolayer and enhances oxidative phosphorylation. J Cell Physiol. 2019 Nov;234(11):19121-19129. doi: 10.1002/jcp.28603. Epub 2019 Apr 2. PMID: 30941770; PMCID: PMC6660401.
10. Issa SM, Sang Y, Granko HA, Wolberg AS. High tranexamic acid concentrations alter fibrin network structure and biophysical properties. J Thromb Haemost. 2025 Sep;23(9):3001-3006. doi: 10.1016/j.jtha.2025.05.012. Epub 2025 May 22. PMID: 40412719; PMCID: PMC12571112.
11. PATCH-Trauma Investigators and the ANZICS Clinical Trials Group; Gruen RL, Mitra B, Bernard SA, McArthur CJ, Burns B, Gantner DC, Maegele M, Cameron PA, Dicker B, Forbes AB, Hurford S, Martin CA, Mazur SM, Medcalf RL, Murray LJ, Myles PS, Ng SJ, Pitt V, Rashford S, Reade MC, Swain AH, Trapani T, Young PJ. Prehospital Tranexamic Acid for Severe Trauma. N Engl J Med. 2023 Jul 13;389(2):127-136. doi: 10.1056/NEJMoa2215457. Epub 2023 Jun 14. PMID: 37314244.
12. Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet. 2018 Jan 13;391(10116):125-132. doi: 10.1016/S0140-6736(17)32455-8. Epub 2017 Nov 7. PMID: 29126600; PMCID: PMC5773762
13. Ali A, Gruen RL, Bernard SA, Burns B, Forbes AB, Gantner DC, McArthur CJ, Maegele M, Mitra B; PATCH-Trauma trial investigators. Tranexamic Acid Timing and Mortality Impact After Trauma. Ann Emerg Med. 2026 Jan;87(1):83-89. doi: 10.1016/j.annemergmed.2025.06.609. Epub 2025 Aug 5. PMID: 40751727.
14. Newman ZC, Ogbeifun VO, Barbosa CE, McKinley WI, Benjamin AJ, Munar MY, Pramuka PE, McGovern KD, Nordgren RK, Schreiber MA, Rowell SE. Intravenous Versus Intraosseous Use of Tranexamic Acid in Patients With Traumatic Brain Injury. J Surg Res. 2024 Oct;302:798-804. doi: 10.1016/j.jss.2024.08.003. Epub 2024 Sep 2. PMID: 39226704.
15. Barrett WJ, Kaucher KA, Orpet RE, Campion EM, Goodloe JM, Fischer PE, Colwell CB, Lyng JW. Tranexamic acid in trauma: A joint position statement and resource document of NAEMSP, ACEP, and ACS-COT. J Trauma Acute Care Surg. 2025 Sep 1;99(3):357-363. doi: 10.1097/TA.0000000000004727. Epub 2025 Aug 18. PMID: 40842057; PMCID: PMC12363306.
16. Grassin-Delyle S, Shakur-Still H, Picetti R, Frimley L, Jarman H, Davenport R, McGuinness W, Moss P, Pott J, Tai N, Lamy E, Urien S, Prowse D, Thayne A, Gilliam C, Pynn H, Roberts I. Pharmacokinetics of intramuscular tranexamic acid in bleeding trauma patients: a clinical trial. Br J Anaesth. 2021 Jan;126(1):201-209. doi: 10.1016/j.bja.2020.07.058. Epub 2020 Sep 30. PMID: 33010927.
17. O'Neil ER, Schmees LR, Resendiz K, Justino H, Anders MM. Inhaled Tranexamic Acid As a Novel Treatment for Pulmonary Hemorrhage in Critically Ill Pediatric Patients: An Observational Study. Crit Care Explor. 2020 Jan 29;2(1):e0075. doi: 10.1097/CCE.0000000000000075. PMID: 32166295; PMCID: PMC7063899.
18. Guyette FX, Brown JB, Zenati MS, Early-Young BJ, Adams PW, Eastridge BJ, Nirula R, Vercruysse GA, O'Keeffe T, Joseph B, Alarcon LH, Callaway CW, Zuckerbraun BS, Neal MD, Forsythe RM, Rosengart MR, Billiar TR, Yealy DM, Peitzman AB, Sperry JL; STAAMP Study Group. Tranexamic Acid During Prehospital Transport in Patients at Risk for Hemorrhage After Injury: A Double-blind, Placebo-Controlled, Randomized Clinical Trial. JAMA Surg. 2020 Oct 5;156(1):11–20. doi: 10.1001/jamasurg.2020.4350. Epub ahead of print. Erratum in: JAMA Surg. 2021 Jan 1;156(1):105. doi: 10.1001/jamasurg.2020.5809. PMID: 33016996; PMCID: PMC7536625.
19. Meer MM, Mumtaz M, Farrukh Z, Ahmed B. Efficacy and Safety of Tranexamic Acid in Traumatic Brain Injury: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cureus. 2024 Nov 15;16(11):e73781. doi: 10.7759/cureus.73781. PMID: 39687834; PMCID: PMC11647055.
20. Li Y, Tian M, Zhong W, Zou J, Duan X, Si H. Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis. Front Med (Lausanne). 2025 Mar 14;12:1552271. doi: 10.3389/fmed.2025.1552271. PMID: 40160319; PMCID: PMC11951308.
21. Bayer J, Kirchner T, Lefering R, Bode L, Schmal H, Wagner FC. Tranexamic acid in multiply injured patients-the independent risk of thromboembolic complications with repeated dosing: retrospective analysis based on the TraumaRegister DGU®. Scand J Trauma Resusc Emerg Med. 2025 Nov 15;33(1):185. doi: 10.1186/s13049-025-01512-1. PMID: 41241739; PMCID: PMC12619269.
22. Deshpande DV, McKinley WI, Benjamin AJ, Schreiber MA, Rowell SE. The Association Between Tranexamic Acid and Seizures in Moderate or Severe Traumatic Brain Injury. J Surg Res. 2024 Sep;301:359-364. doi: 10.1016/j.jss.2024.06.035. Epub 2024 Jul 17. PMID: 39024715.
23. Fouche PF, Stein C, Nichols M, Meadley B, Bendall JC, Smith K, Anderson D, Doi SA. Tranexamic Acid for Traumatic Injury in the Emergency Setting: A Systematic Review and Bias-Adjusted Meta-Analysis of Randomized Controlled Trials. Ann Emerg Med. 2024 May;83(5):435-445. doi: 10.1016/j.annemergmed.2023.10.004. Epub 2023 Nov 22. PMID: 37999653.
24. Bouras M, Bourdiol A, Rooze P, Hourmant Y, Caillard A, Roquilly A. Tranexamic acid: a narrative review of its current role in perioperative medicine and acute medical bleeding. Front Med (Lausanne). 2024 Aug 7;11:1416998. doi: 10.3389/fmed.2024.1416998. PMID: 39170034; PMCID: PMC11335516.
25. Grassin-Delyle S, Semeraro M, Foissac F, Bouazza N, Shakur-Still H, Roberts I, Treluyer JM, Urien S. Tranexamic acid through intravenous, intramuscular and oral routes: an individual participant data meta-analysis of pharmacokinetic studies in healthy volunteers. Fundam Clin Pharmacol. 2019 Dec;33(6):670-678. doi: 10.1111/fcp.12474. Epub 2019 May 14. PMID: 31013357.
26. Stitt G, Spinella PC, Bochicchio GV, Roberts I, Downes KJ, Zuppa AF. Population pharmacokinetic modelling and simulation of tranexamic acid in adult trauma patients. Br J Clin Pharmacol. 2024 Aug;90(8):1932-1941. doi: 10.1111/bcp.16075. Epub 2024 May 2. PMID: 38697615; PMCID: PMC11932107.
27. Dumas RP, Succar BE, Vella MA, Appelbaum RD, Neal MD, Dultz LA, Shah KH, Patel NJ, Brito AM, Kornblith LZ, Murphy PB, Bankhead BK, Sleet MC, Molavi I, Asfaw SH, Schreiber MA, Kutcher ME, Sperry JL, Yang W, Cannon JW, Martin MJ. The use of tranexamic acid in the management of injured patients at risk of hemorrhage: a systematic review and meta-analysis and an Eastern Association for the Surgery of Trauma Practice Management Guideline. J Trauma Acute Care Surg. 2025 Nov 1;99(5):785-794. doi: 10.1097/TA.0000000000004773. Epub 2025 Sep 15. PMID: 40956301.
28. Acharya P, Amin A, Nallamotu S, Riaz CZ, Kuruba V, Senthilkumar V, Kune H, Bhatti SS, Sarlat IM, Krishna CV, Asif K, Nashwan AJ, Cheema HA. Prehospital tranexamic acid in trauma patients: a systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2023 Oct 20;10:1284016. doi: 10.3389/fmed.2023.1284016. PMID: 37928456; PMCID: PMC10623347.
29. Chen HY, Wu LG, Fan CC, Yuan W, Xu WT. Effectiveness and safety of prehospital tranexamic acid in patients with trauma: an updated systematic review and meta-analysis with trial sequential analysis. BMC Emerg Med. 2024 Oct 25;24(1):202. doi: 10.1186/s12873-024-01119-2. PMID: 39455930; PMCID: PMC11515107.
30. Song JX, Wu JX, Zhong H, Chen W, Zheng JC. Therapeutic efficacy of tranexamic acid on traumatic brain injury: a systematic review and meta-analysis. Scand J Trauma Resusc Emerg Med. 2024 Mar 7;32(1):18. doi: 10.1186/s13049-024-01188-z. PMID: 38454455; PMCID: PMC10921791.
31. Knowlton LM, Arnow K, Trickey AW, Sauaia A, Knudson MM. Does tranexamic acid increase venous thromboembolism risk among trauma patients? A prospective multicenter analysis across 17 level I trauma centers. Injury. 2023 Nov;54(11):111008. doi: 10.1016/j.injury.2023.111008. Epub 2023 Aug 23. PMID: 37669883.
32. Karl V, Thorn S, Mathes T, Hess S, Maegele M. Association of Tranexamic Acid Administration With Mortality and Thromboembolic Events in Patients With Traumatic Injury: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 Mar 1;5(3):e220625. doi: 10.1001/jamanetworkopen.2022.0625. PMID: 35230436; PMCID: PMC8889461.
33. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2012 Feb;147(2):113-9. doi: 10.1001/archsurg.2011.287. Epub 2011 Oct 17. PMID: 22006852.
34. Rowell SE, Meier EN, McKnight B, Kannas D, May S, Sheehan K, Bulger EM, Idris AH, Christenson J, Morrison LJ, Frascone RJ, Bosarge PL, Colella MR, Johannigman J, Cotton BA, Callum J, McMullan J, Dries DJ, Tibbs B, Richmond NJ, Weisfeldt ML, Tallon JM, Garrett JS, Zielinski MD, Aufderheide TP, Gandhi RR, Schlamp R, Robinson BRH, Jui J, Klein L, Rizoli S, Gamber M, Fleming M, Hwang J, Vincent LE, Williams C, Hendrickson A, Simonson R, Klotz P, Sopko G, Witham W, Ferrara M, Schreiber MA. Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury. JAMA. 2020 Sep 8;324(10):961-974. doi: 10.1001/jama.2020.8958. Erratum in: JAMA. 2020 Oct 27;324(16):1683. doi: 10.1001/jama.2020.20143. PMID: 32897344; PMCID: PMC7489866.
35. Li SR, Guyette F, Brown J, Zenati M, Reitz KM, Eastridge B, Nirula R, Vercruysse GA, O'Keeffe T, Joseph B, Neal MD, Zuckerbraun BS, Sperry JL. Early Prehospital Tranexamic Acid Following Injury Is Associated With a 30-day Survival Benefit: A Secondary Analysis of a Randomized Clinical Trial. Ann Surg. 2021 Sep 1;274(3):419-426. doi: 10.1097/SLA.0000000000005002. PMID: 34132695; PMCID: PMC8480233.
36. Kane Z, Picetti R, Wilby A, Standing JF, Grassin-Delyle S, Roberts I, Shakur-Still H. Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers. Eur J Pharm Sci. 2021 Sep 1;164:105893. doi: 10.1016/j.ejps.2021.105893. Epub 2021 Jun 1. PMID: 34087356; PMCID: PMC8299544.
37. Mazzei M, Donohue JK, Schreiber M, Rowell S, Guyette FX, Cotton B, Eastridge BJ, Nirula R, Vercruysse GA, O'Keeffe T, Joseph B, Brown JB, Neal MD, Sperry JL. Prehospital tranexamic acid is associated with a survival benefit without an increase in complications: Results of two harmonized randomized clinical trials. J Trauma Acute Care Surg. 2024 Nov 1;97(5):697-702. doi: 10.1097/TA.0000000000004315. Epub 2024 Mar 25. PMID: 38523128; PMCID: PMC11422517.
38. Thomas HM, Kahf H, Bush B, Nahmias J, Lim PK. Use of tranexamic acid in trauma surgical specialties: a narrative review. World J Emerg Surg. 2025 Oct 10;20(1):76. doi: 10.1186/s13017-025-00649-9. PMID: 41074177; PMCID: PMC12512591.
39. Barrett WJ, Kaucher KA, Orpet RE, Campion EM, Goodloe JM, Fischer PE, Colwell CB, Lyng JW. Prehospital Trauma Compendium: Tranexamic Acid in Trauma - A Joint Position Statement and Resource Document of NAEMSP, ACEP, and ACS-COT. Prehosp Emerg Care. 2025 Aug 20:1-8. doi: 10.1080/10903127.2025.2497056. Epub ahead of print. PMID: 40323259.
40. CRASH-2 collaborators; Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011 Mar 26;377(9771):1096-101, 1101.e1-2. doi: 10.1016/S0140-6736(11)60278-X. PMID: 21439633.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Aleksandra Makulec, Aleksandra Szredzka, Katarzyna Otrębska, Dominika Lewandowska, Aleksandra Jóźwik-Szymańska, Natalia Kostecka, Laura Mikuła, Zuzanna Bogdan-Groszyk, Jan Kucharski, Helena Muszyńska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 28
Number of citations: 0
